KR910014103A - 사람의 손톱 처리용 국소 제제 - Google Patents

사람의 손톱 처리용 국소 제제 Download PDF

Info

Publication number
KR910014103A
KR910014103A KR1019910001551A KR910001551A KR910014103A KR 910014103 A KR910014103 A KR 910014103A KR 1019910001551 A KR1019910001551 A KR 1019910001551A KR 910001551 A KR910001551 A KR 910001551A KR 910014103 A KR910014103 A KR 910014103A
Authority
KR
South Korea
Prior art keywords
use according
treatment
topical composition
sulfur
amino acid
Prior art date
Application number
KR1019910001551A
Other languages
English (en)
Inventor
엘베르투스 반 덴 호벤 빌헬름
올토프 마르가레타
Original Assignee
한스 발터 라벤
기스트 브로카데스 나암로제 베노오트하프
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한스 발터 라벤, 기스트 브로카데스 나암로제 베노오트하프 filed Critical 한스 발터 라벤
Publication of KR910014103A publication Critical patent/KR910014103A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음.

Description

사람의 손톱 처리용 국소 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

  1. 사람 손톱의 치료 또는 미용 처리용 국소 조성물의 제조에 있어서서의 일반식
    으로 나타내는 황 함유 아미노산 또는 제약학적으로 허용되는 그의 염의 이용 식중 n=1-4 R=H, 탄소수가 1-12인 알킬 또는 카르복실 아실이다.
  2. 제1항에 있어서, 황 함유 아미노산이 시스테인의 N-카르복실 아실 치환 유도체인 것을 특징으로 하는 이용.
  3. 제2항에 있어서, 시스테인 유도체가 N-아세틸-시스테인(NAC)인 것을 특징으로 하는 이용.
  4. 제3항에 있어서, 국소 조성물에서의 NAC의 농도가 1-40%w/v, 바람직하게는 5-40%w/v, 더욱 바람직하게는 10-20%w/v인 것을 특징으로 하는 이용.
  5. 제1항 내지 제4항중의 어느 한 항에 있어서, 국소 조성물에 국소적으로 효과적인 치료제가 들어 있는 것을 특징으로 하는 이용.
  6. 제5항에 있어서, 치료제가 이미다졸 화합물인 것을 특징으로 하는 이용.
  7. 제6항에 있어서, 이미다졸 화합물이 옥시코나졸인 것을 특징으로 하는 이용.
  8. 제6항에 있어서, 약제가 N-(4-tert-부틸벤질), N-메틸-1-나프틸메틸아민(부테나핀, KP-363)인 것을 특징으로 하는 이용.
  9. 제5항에 있어서, 약제가 코르티코스테로이드인 것을 특징으로 하는 이용.
  10. 제9항에 있어서 코르티코스테로이드가 부데소니드인 것을 특징으로 하는 이용.
  11. 제1항 내지 제10항중의 어느 한 항에 있어서, 국소 조성물에 염료가 들어 있는 것을 특징으로 하는 이용.
  12. 제1항 내지 제11항중의 어느 한 항에 있어서, 국소 조성물이 인스턴트 제제를 포함하여, 로션, 막 형성 로션, 그림, 연고, 겔 또는 페이스트인 것을 특징으로 하는 이용.
  13. 사람 손톱의 치료 또는 미용 처리용 국소 조성물에 있어서 일반식
    으로 나타내는 황 함유 아미노산 또는 제약학적으로 허용되는 그의 염 1% 내지 40%w/v와 제약학적으로 허용되는 담체를 함유하는 것을 특징으로 하는 국소 조성물 식중 n=1-4 R=H, 탄소수가 1-12인 알킬 또는 카르복실 아실이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910001551A 1990-01-30 1991-01-30 사람의 손톱 처리용 국소 제제 KR910014103A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90200209.6 1990-01-30
EP90200209 1990-01-30

Publications (1)

Publication Number Publication Date
KR910014103A true KR910014103A (ko) 1991-08-31

Family

ID=8204926

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910001551A KR910014103A (ko) 1990-01-30 1991-01-30 사람의 손톱 처리용 국소 제제

Country Status (12)

Country Link
EP (1) EP0440298A1 (ko)
KR (1) KR910014103A (ko)
AU (1) AU639975B2 (ko)
CA (1) CA2035263A1 (ko)
FI (1) FI910413A (ko)
HU (1) HUT56717A (ko)
IE (1) IE910317A1 (ko)
IL (1) IL97012A0 (ko)
NO (1) NO910340L (ko)
NZ (1) NZ236929A (ko)
PT (1) PT96592A (ko)
ZA (1) ZA91684B (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5916545A (en) * 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
WO1999049895A2 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
EP1071413B1 (en) * 1998-04-17 2004-06-16 Bertek Pharmaceuticals, Inc. Topical formulations for the treatment of nail fungal diseases
US6808716B2 (en) 1999-01-08 2004-10-26 Ruey J. Yu N-acetylamino acids, related N-acetyl compounds and their topical use
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
AU3928500A (en) * 1999-03-29 2000-10-16 Johnson & Johnson Consumer Companies, Inc. Method for removal of human horny tissues
US8257688B2 (en) 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6821508B2 (en) 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
CA2468539C (en) 2001-10-22 2013-01-08 Michael A. Repka Delivery of medicaments to the nail
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
AU2006339841B2 (en) 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
AU2006339842B2 (en) 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8101664B2 (en) 2007-01-19 2012-01-24 Quinnova Pharmaceuticals, Inc. Urea foam
WO2009031644A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌医薬組成物
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
WO2010117089A2 (en) * 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1485602A (fr) * 1966-03-30 1967-06-23 Nouvelles compositions destinées aux soins des ongles
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
DE2840498C2 (de) * 1978-09-18 1980-04-10 Walter Dr. 6700 Ludwigshafen Schweckendiek Pharmazeutische Zubereitungen zur Behandlung von Psoriasis
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
DE3438005A1 (de) * 1984-10-17 1986-04-17 Röhm GmbH, 6100 Darmstadt Pharmazeutisches mittel zur lokalen therapie der psoriasis
GB2180153A (en) * 1985-09-10 1987-03-25 Rory Ltd Compositions containing acetylcysteine
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
EP0403530A4 (en) * 1988-03-04 1991-09-11 Ciro's Touch, Ltd. Storage-stable compositions and methods for treating keratinous tissue

Also Published As

Publication number Publication date
EP0440298A1 (en) 1991-08-07
AU7003291A (en) 1991-08-01
HU910312D0 (en) 1991-08-28
NO910340L (no) 1991-07-31
PT96592A (pt) 1991-11-29
NZ236929A (en) 1993-12-23
CA2035263A1 (en) 1991-07-31
IL97012A0 (en) 1992-03-29
FI910413A (fi) 1991-07-31
NO910340D0 (no) 1991-01-29
AU639975B2 (en) 1993-08-12
ZA91684B (en) 1991-10-30
HUT56717A (en) 1991-10-28
FI910413A0 (fi) 1991-01-28
IE910317A1 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
KR910014103A (ko) 사람의 손톱 처리용 국소 제제
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
DE3679722D1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
DE60001544T2 (de) Kreatin, Karnitin und/oder Brenztraubensäure enthaltende kosmetische Zusammensetzungen
GB2180153A (en) Compositions containing acetylcysteine
DE69806962T2 (de) FSNMU als entzündungshemmende Mittel in den oberflächen Geweben von Säugetieren
KR960010002A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
CA2237995A1 (fr) Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
BR9708297A (pt) Compostos composição farmacéutica cosmposição e uso de uma composição cosmética
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
KR970707091A (ko) 스핑고이드 염기의 레티노일아미드계 유도체(retinoylamide based derivatives of sphingoid bases)
BR9807330A (pt) Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
BR9809744A (pt) Antifúngicos de azol contendo éster de aminoácido
KR970032819A (ko) 미백화장료 조성물
KR940000094A (ko) 화장제 조성물
KR940018351A (ko) 노나테트라에노산 유도체
KR980002033A (ko) 트리아졸 유도체 또는 그 염
JPH04108721A (ja) 細胞賦活剤組成物
KR930701976A (ko) 알칸 아미도 암모늄 화합물의 신규용도
KR970014747A (ko) 화장료 조성물

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid